Shuji Mikami

6.4k total citations
206 papers, 4.1k citations indexed

About

Shuji Mikami is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Shuji Mikami has authored 206 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Pulmonary and Respiratory Medicine, 73 papers in Molecular Biology and 63 papers in Surgery. Recurrent topics in Shuji Mikami's work include Renal cell carcinoma treatment (59 papers), Bladder and Urothelial Cancer Treatments (36 papers) and Renal and related cancers (34 papers). Shuji Mikami is often cited by papers focused on Renal cell carcinoma treatment (59 papers), Bladder and Urothelial Cancer Treatments (36 papers) and Renal and related cancers (34 papers). Shuji Mikami collaborates with scholars based in Japan, United States and Czechia. Shuji Mikami's co-authors include Mototsugu Oya, Takeo Kosaka, Eiji Kikuchi, Ryuichi Mizuno, Yasunori Okada, Akira Miyajima, Masahiro Jinzaki, Yoji Nagashima, Nobuyuki Tanaka and Hirotaka Akita and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shuji Mikami

192 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuji Mikami Japan 36 1.7k 1.5k 1.3k 955 611 206 4.1k
Mathilde Sibony France 33 2.0k 1.2× 1.4k 0.9× 1.4k 1.1× 735 0.8× 911 1.5× 128 4.4k
Yukio Kageyama Japan 30 1.6k 1.0× 999 0.6× 1.0k 0.8× 817 0.9× 757 1.2× 152 3.5k
Zhong Jiang United States 42 2.2k 1.3× 1.8k 1.2× 1.1k 0.8× 794 0.8× 1.2k 2.0× 129 4.6k
David Waltregny Belgium 38 2.3k 1.4× 932 0.6× 1.3k 1.0× 1.0k 1.1× 843 1.4× 98 5.1k
Hiroshi Kanetake Japan 34 2.0k 1.2× 1.1k 0.7× 959 0.8× 899 0.9× 796 1.3× 210 4.1k
Hiro‐omi Kanayama Japan 35 1.9k 1.1× 1.4k 0.9× 967 0.8× 1.0k 1.1× 967 1.6× 195 4.0k
Andres Jan Schrader Germany 34 1.1k 0.7× 2.0k 1.3× 707 0.6× 1.2k 1.2× 844 1.4× 162 3.8k
Tomohiko Asano Japan 27 1.5k 0.9× 804 0.5× 763 0.6× 1.0k 1.1× 635 1.0× 180 3.6k
Naoki Okumura Japan 42 1.6k 0.9× 1.1k 0.7× 663 0.5× 663 0.7× 352 0.6× 222 6.2k
Thomas B. Crotty United States 29 1.1k 0.6× 1.4k 0.9× 782 0.6× 553 0.6× 716 1.2× 64 3.8k

Countries citing papers authored by Shuji Mikami

Since Specialization
Citations

This map shows the geographic impact of Shuji Mikami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Mikami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Mikami more than expected).

Fields of papers citing papers by Shuji Mikami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuji Mikami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Mikami. The network helps show where Shuji Mikami may publish in the future.

Co-authorship network of co-authors of Shuji Mikami

This figure shows the co-authorship network connecting the top 25 collaborators of Shuji Mikami. A scholar is included among the top collaborators of Shuji Mikami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuji Mikami. Shuji Mikami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mikami, Shuji, et al.. (2024). Multifocal meningoencephalitis after vaccination against COVID‐19. Pathology International. 74(12). 697–703.
2.
Shigeta, Keisuke, Masanori Hasegawa, Takako Hishiki, et al.. (2023). IDH2 stabilizes HIF ‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO Journal. 42(4). e110620–e110620. 49 indexed citations
3.
Mikami, Shuji, et al.. (2023). Sigmoid Colon Cancer Masked by Refractory Diverticulitis With Abscess. Cureus. 15(11). e48326–e48326.
4.
Komori, Takahiro, Takeo Kosaka, Keitaro Watanabe, et al.. (2022). Salvage focal brachytherapy in castration‐resistant prostate cancer with neuroendocrine differentiation after radiation therapy. IJU Case Reports. 5(4). 233–236. 2 indexed citations
5.
Kosaka, Takeo, Hiroaki Kobayashi, Kohei Nakamura, et al.. (2022). Castration-resistant prostate cancer patient presenting with whole genome doubling with CDK-12 mutation. BMC Medical Genomics. 15(1). 32–32. 3 indexed citations
6.
Hayashida, Tetsu, Tomoko Seki, Maiko Takahashi, et al.. (2018). IgG4‐related mastopathy: A case report and literature review. Clinical Case Reports. 6(8). 1549–1553. 13 indexed citations
7.
Kosaka, Takeo, Shuji Mikami, Ari Hashimoto, et al.. (2017). 上部尿路尿路上皮癌における赤血球蛋白質バンド4.1like5発現の予後的意義【Powered by NICT】. Urologic Oncology Seminars and Original Investigations. 35(9). 17–543. 1 indexed citations
8.
Nishimoto, Koshiro, Tsugio Seki, Yuichiro Hayashi, et al.. (2016). Human Adrenocortical Remodeling Leading to Aldosterone-Producing Cell Cluster Generation. International Journal of Endocrinology. 2016. 1–6. 43 indexed citations
9.
Sugimoto, Shinya, Makoto Naganuma, Yasushi Iwao, et al.. (2016). Endoscopic morphologic features of ulcerative colitis–associated dysplasia classified according to the SCENIC consensus statement. Gastrointestinal Endoscopy. 85(3). 639–646.e2. 35 indexed citations
10.
11.
Dowaki, Shoichi, Koji Fujita, Kei‐ichi Ishikawa, et al.. (2015). Endoscopic biliary drainage as a bridging procedure to single-stage surgery for perforated choledochal cyst: a case report and review of the literature. Surgical Case Reports. 1(1). 117–117. 10 indexed citations
12.
Takamatsu, Kimiharu, et al.. (2015). A case of paraneoplastic liver dysfunction with elevated serum interleukin-6 in clinically localized renal cell carcinoma. International Cancer Conference Journal. 5(1). 66–67.
13.
Tsujikawa, Takahiro, Tomonori Yaguchi, Naoshi Kawamura, et al.. (2014). Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC. Molecular Cancer Research. 13(4). 721–731. 44 indexed citations
14.
Miyazaki, Yasumasa, Takeo Kosaka, Shuji Mikami, et al.. (2012). The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma. Clinical Cancer Research. 18(15). 4145–4153. 38 indexed citations
15.
Toda, Masahiro, Hikaru Sasaki, Yohei Kitamura, et al.. (2012). Infratentorial low-grade oligoastrocytoma with aggressive clinical behavior in an adult: a case report with genetic characterization. Brain Tumor Pathology. 30(2). 99–103. 2 indexed citations
16.
Nishimoto, Koshiro, Ken Nakagawa, Dan Li, et al.. (2010). Adrenocortical Zonation in Humans under Normal and Pathological Conditions. The Journal of Clinical Endocrinology & Metabolism. 95(5). 2296–2305. 237 indexed citations
17.
Kikuchi, Eiji, Vitaly Margulis, Pierre I. Karakiewicz, et al.. (2008). Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma. Journal of Clinical Oncology. 27(4). 612–618. 215 indexed citations
18.
Mikami, Shuji, Yuichi Hirose, Kazunari Yoshida, et al.. (2007). Predominant expression of OLIG2 over ID2 in oligodendroglial tumors. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 450(5). 575–584. 5 indexed citations
19.
Oguma, Junya, Soji Ozawa, Tai Omori, et al.. (2005). EMR of a hyperplastic polyp arising in ectopic gastric mucosa in the cervical esophagus: case report. Gastrointestinal Endoscopy. 61(2). 335–338. 12 indexed citations
20.
Oya, Mototsugu, Shuji Mikami, Ryuichi Mizuno, et al.. (2004). Differential expression of activator protein-2 isoforms in renal cell carcinoma. Urology. 64(1). 162–167. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mathilde Sibony Breakdown of academic impact, for papers by Yukio Kageyama Breakdown of academic impact, for papers by Zhong Jiang Breakdown of academic impact, for papers by David Waltregny Breakdown of academic impact, for papers by Hiroshi Kanetake Breakdown of academic impact, for papers by Hiro‐omi Kanayama Breakdown of academic impact, for papers by Andres Jan Schrader Breakdown of academic impact, for papers by Tomohiko Asano Breakdown of academic impact, for papers by Naoki Okumura Breakdown of academic impact, for papers by Thomas B. Crotty
Rankless by CCL
2026